Stock CRON CRONOS GROUP INC.
Add to a list
To use this feature you must be a member
Log inSign up

Company Cronos Group Inc. Nasdaq

Equities

CRON

CA22717L1013

Pharmaceuticals

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-26 pm EDT 		5-day change 1st Jan Change
2.59 USD +3.60% Intraday chart for Cronos Group Inc. +9.28% +23.92%
Apr. 02 Cannabis Stocks: Wedbush Notes Florida Supreme Court Approved Proposed Amendment For Adult Use Cannabis to be Placed on the 2024 General Election Ballot MT
Mar. 25 Cronos Group Brief: Launching 'Lord Jones' Chocolate Fusions MT

Business Summary

Cronos Group Inc. is a Canada-based global cannabinoid company engaged in building intellectual property by advancing cannabis research, technology and product development. The Company’s segments include United States and Rest of World. The United States operating segment consists of the manufacture and distribution of hemp-derived CBD infused products. The Rest of World operating segment is involved in the cultivation, manufacture, and marketing of cannabis and cannabis-derived products for the medical and adult-use markets. The Company’s international brand portfolio includes Spinach, PEACE NATURALS, and Lord Jones. The Lord Jones are hemp-derived cannabidiol (CBD) brand. Its Lord Jones Hash Fusions is a line-up of premium ice water hash infused pre-rolls. Its PEACE NATURALS offers Peppermint CBD, a blend of CBD extract, quality medium-chain triglycerides (MCT) oil, and a hint of natural peppermint flavor.

Number of employees: 356

Sales per Business

CAD in Million2022Weight2023Weight Delta
Cannabis Flower
71.1 %
83 69.2 % 84 71.1 % +1.19%
Cannabis Extracts
28.2 %
36 30.1 % 33 28.2 % -7.97%
Other
0.7 %
1 0.7 % 1 0.7 % -1.56%

Sales per region

CAD in Million2022Weight2023Weight Delta
Canada
74.2 %
-- 87 74.2 % -
Israel
24.2 %
-- 29 24.2 % -
Other Countries
1.6 %
113 94.4 % 2 1.6 % -98.32%

Managers

Managers TitleAgeSince
Michael Gorenstein CEO
 Chief Executive Officer 37 15-11-05
James Holm DFI
 Director of Finance/CFO 41 22-11-13
Arye Weigensberg CTO
 Chief Tech/Sci/R&D Officer 41 -
Shayne Laidlaw IRC
 Investor Relations Contact - -
Terry Doucet LAW
 General Counsel - 17-12-31
Ran Gorelik PRN
 Corporate Officer/Principal 63 -
James Mcginness AUD
 Comptroller/Controller/Auditor 46 23-05-21
Shannon Buggy HRO
 Human Resources Officer 54 -
Jeffrey Jacobson PRN
 Corporate Officer/Principal 38 15-12-31

Members of the board

Members of the board TitleAgeSince
Kendrick F. Ashton BRD
 Director/Board Member 48 21-06-24
James D. Rudyk BRD
 Director/Board Member 57 18-01-31
Jason Adler BRD
 Director/Board Member 52 16-07-11
Michael Gorenstein CEO
 Chief Executive Officer 37 15-11-05
Kamran Khan BRD
 Director/Board Member 50 23-06-21
Dominik Meier BRD
 Director/Board Member 46 23-06-21
Elizabeth Seegar BRD
 Director/Board Member 46 23-06-21

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 382,011,178 200,088,959 ( 52.38 %) 0 52.38 %

Shareholders

NameEquities%Valuation
ALTRIA GROUP, INC.
41.06 %
156,573,537 41.06 % 409 M $
Jason Adler
3.799 %
14,487,111 3.799 % 38 M $
Michael Gorenstein
2.648 %
10,097,416 2.648 % 26 M $
Chescapmanager LLC
2.184 %
8,327,090 2.184 % 22 M $
Vanguard Fiduciary Trust Co.
1.856 %
7,078,051 1.856 % 18 M $
ETF Managers Group LLC
1.416 %
5,399,750 1.416 % 14 M $
Dimensional Fund Advisors LP
0.5258 %
2,004,781 0.5258 % 5 M $
Susquehanna Securities LLC
0.3559 %
1,357,213 0.3559 % 4 M $
Millennium Management LLC
0.3299 %
1,258,057 0.3299 % 3 M $
Group One Trading LP
0.2777 %
1,058,718 0.2777 % 3 M $

Holdings

NameEquities%Valuation
VITURA HEALTH LIMITED
9.58%
 55,176,065 9.58% 6,839,625 $

Company contact information

Cronos Group, Inc.

111 Peter Street Suite 300

M5V 2H1, Toronto

+416 504 0004

http://www.thecronosgroup.com
address Cronos Group Inc.(CRON)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Alternative Medicine

Sales per Business

Sales per region

Ratings for Cronos Group Inc.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
8
Last Close Price
3.53 CAD
Average target price
3.567 CAD
Spread / Average Target
+1.05%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Alternative Medicine

1st Jan change Capi.
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD. Stock Shijiazhuang Yiling Pharmaceutical Co., Ltd.
-15.13% 4.51B
TASLY PHARMACEUTICAL GROUP CO., LTD Stock Tasly Pharmaceutical Group Co., Ltd
-9.75% 3.15B
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED Stock Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited
+2.14% 3.1B
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD. Stock Shandong Buchang Pharmaceuticals Co., Ltd.
-6.82% 2.42B
HENAN LINGRUI PHARMACEUTICAL CO., LTD. Stock Henan Lingrui Pharmaceutical Co., Ltd.
+47.87% 1.97B
TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD. Stock Tibet Cheezheng Tibetan Medicine Co., Ltd.
+0.09% 1.65B
GUANGYUYUAN CHINESE HERBAL MEDICINE CO., LTD. Stock GuangYuYuan Chinese Herbal Medicine Co., Ltd.
-7.89% 1.68B
TIANJIN CHASE SUN PHARMACEUTICAL CO.,LTD Stock Tianjin Chase Sun Pharmaceutical Co.,Ltd
-12.97% 1.53B
ZHEJIANG JOLLY PHARMACEUTICAL CO.,LTD Stock Zhejiang Jolly Pharmaceutical Co.,LTD
+33.40% 1.38B
Alternative Medicine
  1. Stock Market
  2. Equities
  3. CRON Stock
  4. CRON Stock
  5. Company Cronos Group Inc.